Possible role of S-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice

Journal of Clinical Biochemistry and Nutrition

Volumn 53, Issue 1, 2013, Pages 41-48

  Nishide, Yoriko ^a,b   Tadaishi, Miki ^a   Kobori, Masuko ^c   Tousen, Yuko ^a   Kato, Michiko ^a   Inada, Masaki ^b   Miyaura, Chisato ^b   Ishimi, Yoshiko ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Bone loss; Inflammatory related gene; Isoflavone; Ovariectomized mice; S equol

Indexed keywords

EQUOL; S EQUOL; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; BONE MASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESTROGEN DEFICIENCY; FEMALE; GENE EXPRESSION; HEMATOPOIESIS; METAPHYSIS; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; RANDOMIZED CONTROLLED TRIAL; SHAM PROCEDURE; TRABECULAR BONE;

EID: 84881268290     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-123     Document Type: Article

References (50)

1. Stránský M, Rysavá L. Nutrition as prevention and treatment of osteoporosis. Physiol Res 2009;58(Suppl 1):S7-S11.
2. Brown LB, Streeten EA, Shapiro JR, et al. Genetic and environmental influences on bone mineral density in pre-and post-menopausal women. Osteoporos Int 2005;16:1849-1856.
3. Christiansen C, Lindsay R. Estrogens, bone loss and preservation. Osteoporos Int 1990;1:7-13.
4. Masuzawa T, Miyaura C, Onoe Y, et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 1994;94:1090-1097.
5. Kincade PW, Medina KL, Payne KJ, et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000;175:128-137.
6. Clowes JA, Riggs BL, Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 2005;208:207-227.
7. Miyaura C, Onoe Y, Inada M, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997;94:9360-9365.
8. Cenci S, Weitzmann MN, Roggia C, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α. J Clin Invest 2000;106:1229-1237.
9. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 2001;98:13960-13965.
10. Messina M. A brief historical overview of the past two decades of soy and isoflavone research. J Nutr 2010;140:1350S-1354S.
11. Morito K, Hirose T, Kinjo J, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001;24:351-356.
12. Ishimi Y. Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice. J Nutr 2010;140:1373S-1376S.
13. Setchell KD, Clerici C, Lephart ED, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005;81:1072-1079.
14. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002;3:364-373.
15. Vatanparast H, Chilibeck PD. Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype? Nutr Rev 2007;65:294-299.
16. Tousen Y, Ezaki J, Fujii Y, Ueno T, Nishimuta M, Ishimi Y. Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial. Menopause 2011;18:563-574.
17. Fujioka M, Uehara M, Wu J, et al. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr 2004;134:2623-2627.
18. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-1951.
19. Staudt LM, Clerc RG, Singh H, Le Bowitz JH, Sharp PA, Baltimore D. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science 1988;241:577-580.
20. Hemingway F, Taylor R, Knowles HJ, Athanasou NA. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011;48:938-944.
21. Grewal IS, Flavell RA. The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 1996;153:85-106.
22. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. BIood 2005;105:13-21.
23. Nakashima T, Takayanagi H. Osteoclasts and the immune system. J Bone Miner Metab 2009;27:519-529.
24. Ntambi JM, Young-Cheul K. Adipocyte differentiation and gene expression. J Nutr 2000;130:3122S-3126S.
25. Paulauskis JD, Sul HS. Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells. J Biol Chem 1988;263:7049-7054.
26. Kimira Y, Katsumata S, Suzuki K, et al. Comparative activities of the S-enantiomer and racemic forms of equol on bone fragility in ovariectomized mice. Biosci Biotechnol Biochem 2012;76:1018-1021.
27. Yoneda T, Ueno T, Uchiyama S. S-equol and the fermented soy product SE5-OH containing S-equol similarly decrease ovariectomy-induced increase in rat tail skin temperature in an animal model of hot flushes. Menopause 2011;18:814-820.
28. Setchell KD, Zhao X, Jha P, Heubi JE, Brown NM. The pharmacokinetic behavior of the soy isoflavone metabolite S-(-) equol and its diastereoisomer R-(+) equol in healthy adults determined by using stable-isotope-labeled tracers. Am J Clin Nutr 2009;90:1029-1037.
29. Schwen RJ, Nguyen L, Plomley JB, Jackson RL. Toxicokinetics and lack of uterotropic effect of orally administered S-equol. Food Chem Toxicol 2012;50:1741-1748.
30. Setchell KD, Clerici C. Equol: pharmacokinetics and biological actions. J Nutr 2010;140:1363S-1368S.
31. Schwen R, Jackson R, Proudlock R. Genotoxicity assessment of S-equol in bacterial mutation, chromosomal aberration, and rodent bone marrow micronucleus tests. Food Chem Toxicol 2010;48:3481-3485.
32. Kalu DN, Salerno E, Liu CC, Ferarro F, Arjmandi BN, Salih MA. Ovariectomy-induced bone loss and the hematopoietic system. Bone Miner 1993;23:145-161.
33. Milne CD, Paige CJ. IL-7:a key regulator of B lymphopoiesis. Semin Immunol 2006;18:20-30.
34. Carrette F, Surh CD. IL-7 signaling and CD 127 receptor regulation in the control of T cell homeostasis. Semin Immunol 2012;24:209-217.
35. Weitzmann MN, Cenci S, Rifas L, Brown C, Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 2000;96:1873-1878.
36. Weitzmann MN, Roggia C, Toraldo G, Weitzmann L, Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002;110:1643-1650.
37. Horowitz MC, Fretz JA, Lorenzo JA. How B cells influence bone biology in health and disease. Bone 2010;47:472-479.
38. Ishimi Y, Miyaura C, Ohmura M, et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999;140:1893-1900.
39. Pacifici R. Role of T cells in ovariectomy induced bone loss-revisited. J Bone Miner Res 2012;27:231-239.
40. Li Y, Toraldo G, Li A, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 2007;109:3839-3848.
41. Tyagi AM, Srivastava K, Kureel J, et al. Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss. Osteoporos Int 2012;23:1151-1161.
42. *CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS One 2011;6:e21216.
43. Duque G, Troen BR. Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome. J Am Geriatr Soc 2008;56:935-941.
44. Akune T, Ohba S, Kamekura S, et al. PPARγinsufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113:846-855.
45. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME. Playing with bone and fat. J Cell Biochem 2006;98:251-266.
46. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 2002;143:2349-2356.
47. Dang ZC, Van Bezooijen RL, Karperien M, Papapoulos SE, Löwik CW. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 2002;17:394-405.
48. Elbaz A, Rivas D, Duque G. Effect of estrogens on bone marrow adipogenesis and Sirtl in aging C57BL/6J mice. Biogerontology 2009;10:747-755.
49. De Heredia FP, Gómez-Martinez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc 2012;71:332-338.
50. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.